Morbidity and mortality from medical errors: an increasingly serious public health problem

Annual Review of Public Health
David P Phillips, Charlene C Bredder

Abstract

From 1983 to 1998, U.S. fatalities from acknowledged prescription errors increased by 243%, from 2,876 to 9,856. This percentage increase was greater than for almost any other cause of death, and far outpaced the increase in the number of prescriptions. Many nonfatal prescription errors also occur, but estimates of the frequency of these errors vary widely, because various definitions, geographic settings, and institutions have been used. Efforts to reduce fatal and nonfatal prescription errors have encountered perceptual, legal, medical, and cultural barriers. It may be possible to reduce prescription errors by instituting a central agency responsible for collecting, analyzing, and reporting harmful or potentially harmful drug events, and for issuing recommendations and directives.

References

Dec 9, 1976·The New England Journal of Medicine·C J McDonald
Jan 5, 1989·The New England Journal of Medicine·D M Berwick
Oct 25, 1995·JAMA : the Journal of the American Medical Association·K GrumbachR Brook
Oct 1, 1995·Journal of Nursing Care Quality·P G Ribnick, V A Carrano
Jul 5, 1995·JAMA : the Journal of the American Medical Association·D W BatesR Hallisey
Jul 5, 1995·JAMA : the Journal of the American Medical Association·L L LeapeG Laffel
Feb 1, 1995·Critical Care Medicine·Y DonchinS Cotev
Dec 1, 1994·Annals of Internal Medicine·L A PetersenT H Lee
Jan 1, 1994·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·B RolinskiF D Goebel
Oct 13, 1993·JAMA : the Journal of the American Medical Association·J Glasson, D Orentlicher
Jan 22, 1997·JAMA : the Journal of the American Medical Association·D W BatesL L Leape
Jul 28, 1997·Archives of Internal Medicine·T S LesarH Pohl
Jan 22, 1998·The New England Journal of Medicine·R S EvansJ P Burke
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M MacklisM S Weinhous
Jun 10, 1998·Lancet·C Rooney
Sep 28, 1998·JAMA : the Journal of the American Medical Association·M R Chassin, R W Galvin
Oct 17, 1998·European Journal of Pediatrics·D G WilsonA G Stuart
Oct 30, 1998·JAMA : the Journal of the American Medical Association·D W BatesD L Seger
Jan 8, 1999·The Milbank Quarterly·M R Chassin
Jan 8, 1999·The Milbank Quarterly·D Blumenthal, C M Kilo
Mar 17, 2000·BMJ : British Medical Journal·S N WeingartB Harrison
Apr 13, 2000·The New England Journal of Medicine·T A Brennan
Apr 29, 2000·Journal of Clinical Nursing·E O'Shea
Jun 29, 2000·JAMA : the Journal of the American Medical Association·C J McDonaldS L Hui
Jun 29, 2000·JAMA : the Journal of the American Medical Association·L L Leape
Aug 5, 2000·Annals of Emergency Medicine·R L WearsR Woolard
Sep 1, 2000·The American Journal of Medicine·P A Chyka

❮ Previous
Next ❯

Citations

Mar 12, 2011·International Journal of Clinical Pharmacy·Hossein KhaliliSimin Dashti-Khavidaki
Jun 1, 2010·Journal of General Internal Medicine·David P Phillips, Gwendolyn E C Barker
Dec 25, 2003·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·S Boufous, A Williamson
Mar 16, 2005·Pharmacotherapy·David P PhillipsRosalie R Phillips
Sep 1, 2004·Expert Opinion on Drug Safety·James G Anderson
Aug 10, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Nicola CassidyJoseph A Tracey
Nov 30, 2013·Fertility and Sterility·Richard T Scott, Nathalie De Ziegler
Jul 25, 2015·Journal of the American Pharmacists Association : JAPhA·Mark T HoldsworthErnest J Dole
Oct 13, 2009·European Journal of Internal Medicine·Michael DetersAndreas Schaper
Dec 8, 2004·Critical Care Clinics·Beau DuweJohn Hansen-Flaschen
Jul 28, 2006·International Journal of Medical Informatics·James G AndersonCarl A Sirio
Oct 14, 2003·Journal of Biomedical Informatics·Matthew B WeingerNelda Ordonez
May 30, 2014·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Mary W CarterFrank W Porell
Nov 2, 2019·Patient Safety in Surgery·Arinze Duke George NwosuElias Chikee Aniwada
Jun 5, 2021·Quality Management in Health Care·M KhammarniaM Peyvand
Sep 5, 2003·Joint Commission Journal on Quality and Safety·Benjamin C GrassoDavid W Bates
Jun 5, 2003·Pediatrics·César Abadía-BarreroGrace Peters

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.